PepGen Shares Quarterly Newsletter

April 10, 2023

On April 7, 2023, PepGen shared a quarterly newsletter which announces that their Phase 2 DMD trials, Connect1-EDO51 and Connect2-EDO51, are planned to start this year and more.

To view PepGen’s quarterly newsletter, please click here.

Experience the magic of camp promise

Complete applications due April 3, 2023.